A5 Labs said that the custom-made LIMS system will allow its CRO customers to track and receive real-time information on the progress and status of the analysis of their products.
The customers will use the Web-based LIMS system to submit requisitions and track the results of the analysis at each stage of the testing as well as purchase copy of the raw data.
A5 Labs president and CEO Richard Azani said that the validation of the LIMS system is a critical step in the start of pharmaceutical CRO business.
"We anticipate that the LIMS system will significantly increase the productivity of our CRO and will deliver total Quality Assurance to our customers on a timely manner," Azani said.
A5 Labs is a contract research based organization servicing the pharmaceutical and biotechnology companies in North America. The company utilises its research capabilities to license and acquire novel biotechnology products for development and commercialisation.